PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Krystelle Godbout, MD, FRCPC - Biomarkers Breakdown in Severe Asthma: Following the Science From Bench to Bedside
Visit https://www.peervoice.com/VFR860 to view the entire programme with slides. After completing “Krystelle Godbout, MD, FRCPC - Biomarkers Breakdown in Severe Asthma: Following the Science From Bench to Bedside”, participants will be able to: Evaluate the latest clinical evidence with novel biologic therapies for severe uncontrolled asthma; Review the long-term efficacy and safety data of eosinophil depletion to optimize outcomes in patients with severe asthma; and Apply strategies to tailor biologic therapy selection for patients with severe asthma, based on patient and treatment characteristics.